GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » SC Ropharma SA (BSE:RPH) » Definitions » Equity-to-Asset

SC Ropharma (BSE:RPH) Equity-to-Asset : 0.30 (As of Dec. 2023)


View and export this data going back to 1997. Start your Free Trial

What is SC Ropharma Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. SC Ropharma's Total Stockholders Equity for the quarter that ended in Dec. 2023 was lei240 Mil. SC Ropharma's Total Assets for the quarter that ended in Dec. 2023 was lei808 Mil. Therefore, SC Ropharma's Equity to Asset Ratio for the quarter that ended in Dec. 2023 was 0.30.

The historical rank and industry rank for SC Ropharma's Equity-to-Asset or its related term are showing as below:

BSE:RPH' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.27   Med: 0.41   Max: 0.45
Current: 0.3

During the past 13 years, the highest Equity to Asset Ratio of SC Ropharma was 0.45. The lowest was 0.27. And the median was 0.41.

BSE:RPH's Equity-to-Asset is ranked worse than
68.19% of 679 companies
in the Healthcare Providers & Services industry
Industry Median: 0.46 vs BSE:RPH: 0.30

SC Ropharma Equity-to-Asset Historical Data

The historical data trend for SC Ropharma's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SC Ropharma Equity-to-Asset Chart

SC Ropharma Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.27 0.41 0.43 0.30 0.30

SC Ropharma Semi-Annual Data
Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.43 0.31 0.30 0.30 0.30

Competitive Comparison of SC Ropharma's Equity-to-Asset

For the Pharmaceutical Retailers subindustry, SC Ropharma's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SC Ropharma's Equity-to-Asset Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, SC Ropharma's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where SC Ropharma's Equity-to-Asset falls into.



SC Ropharma Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

SC Ropharma's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Equity to Asset (A: Dec. 2023 )=Total Stockholders Equity/Total Assets
=240.083/807.775
=0.30

SC Ropharma's Equity to Asset Ratio for the quarter that ended in Dec. 2023 is calculated as

Equity to Asset (Q: Dec. 2023 )=Total Stockholders Equity/Total Assets
=240.083/807.775
=0.30

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


SC Ropharma  (BSE:RPH) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


SC Ropharma Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of SC Ropharma's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


SC Ropharma (BSE:RPH) Business Description

Traded in Other Exchanges
N/A
Address
Str. Iuliu Maniu Nr. 55, ETAJ 1, Brasow, ROU, 500091
SC Ropharma SA is engaged in the production, distribution, and Retail sale of pharmaceutical products in specialized stores. Its product portfolio comprises over 50 products in the form of tablets, powders, capsules, and syrups covering 21 therapeutic areas.

SC Ropharma (BSE:RPH) Headlines

No Headlines